Fredag 4 April | 07:04:40 Europe / Stockholm

Bifogade filer

2025-03-25 15:56:39

Mangold Insight follows up on the previous interview with Mikael Lindstam, CEO at Aptahem, from BIO-Europe in Milan. In this interview, Mikael explains in more detail about the potential of its drug candidate Apta-1, the coming phase 2 study, and the next steps.